14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:XLRN
Delisted

Acceleron Pharma Inc. Stock Price (Quote)

$178.75
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $178.75 $178.75 Friday, 27th May 2022 XLRN stock ended at $178.75. During the day the stock fluctuated 0% from a day low at $178.75 to a day high of $178.75.
90 days $178.75 $178.75
52 weeks $113.49 $189.99

Historical Acceleron Pharma Inc. prices

Date Open High Low Close Volume
Jul 08, 2021 $117.62 $121.46 $116.89 $119.27 400 291
Jul 07, 2021 $127.76 $127.76 $118.40 $119.31 590 395
Jul 06, 2021 $125.65 $127.14 $122.58 $127.07 435 319
Jul 02, 2021 $129.19 $129.40 $126.19 $126.33 362 588
Jul 01, 2021 $125.96 $129.31 $124.34 $128.89 417 764
Jun 30, 2021 $124.56 $125.95 $123.07 $125.49 453 677
Jun 29, 2021 $126.82 $127.12 $122.03 $124.49 283 182
Jun 28, 2021 $128.43 $129.75 $126.59 $127.40 337 463
Jun 25, 2021 $123.92 $127.71 $123.34 $127.22 508 029
Jun 24, 2021 $123.22 $124.95 $122.39 $123.93 290 347
Jun 23, 2021 $124.49 $125.62 $122.14 $122.19 172 107
Jun 22, 2021 $128.11 $128.46 $123.75 $124.47 289 927
Jun 21, 2021 $128.69 $129.83 $127.00 $128.30 156 515
Jun 18, 2021 $126.37 $129.00 $125.13 $128.24 578 708
Jun 17, 2021 $126.87 $128.28 $125.44 $127.32 174 311
Jun 16, 2021 $128.84 $129.87 $125.92 $126.74 153 253
Jun 15, 2021 $130.32 $130.96 $127.16 $128.71 240 745
Jun 14, 2021 $133.85 $135.06 $130.15 $131.06 248 150
Jun 11, 2021 $131.48 $133.60 $130.87 $133.44 243 139
Jun 10, 2021 $126.78 $131.10 $125.95 $130.87 240 806
Jun 09, 2021 $125.00 $127.55 $124.54 $126.51 147 049
Jun 08, 2021 $127.96 $127.96 $123.66 $125.14 148 648
Jun 07, 2021 $124.49 $128.08 $124.00 $126.69 348 966
Jun 04, 2021 $124.30 $125.56 $122.00 $124.52 258 421
Jun 03, 2021 $123.41 $125.01 $122.28 $123.18 203 801
Click to get the best stock tips daily for free!

About Acceleron Pharma Inc.

Acceleron Pharma. Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... XLRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT